INOVIO (NASDAQ: INO) reported third-quarter 2025 results and detailed a series of regulatory and clinical milestones that ...

Tabelecleucel BLA currently under U.S. Food and Drug Administration (FDA) Priority Review as potentially the first approved therapy in the U.S. for EBV+ PTLD with a Prescription Drug User Fee Act ...

Big League Advance Fund recently petitioned the Superior Court of District of Columbia to confirm an arbitration award against San Diego Padres outfielder Fernando Tatis Jr., who has been ordered to ...

Management reiterated plans to initiate the REVEAL pivotal trial for TSHA-102, with the first patient dosing scheduled for the current quarter and additional enrollment expected across multiple sites.

On Tuesday, the U.S. Food and Drug Administration (FDA) accepted Rocket Pharmaceuticals, Inc.’s (NASDAQ:RCKT) resubmission of the Biologics License Application (BLA) for Kresladi (marnetegragene ...

Aspen Neuroscience’s cash reserves have been fertilized with a $115 million series C fundraise that will enrich the biotech’s ...

San Diego Padres star Fernando Tatis Jr. has been ordered by an arbitrator to pay Big League Advance (BLA) $3.74 million. BLA recently petitioned the Superior Court of District of Columbia to confirm ...